Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.

Selective stock-picking and conviction drove HB Biotech’s strong 2024 performance. Read our insights on navigating today’s ...

Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications to lower their weight compared with whites, new research suggests. The ...

Mitolyn is a new dietary supplement that recently hit the market, and is said to be the ultimate weight loss solution. The ...

While we’re unlikely to see a dramatic rise in deaths from vaccine-preventable diseases in the U.S. in the near term, the ...

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...